OSTUZZI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 3.948
NA - Nord America 3.411
AS - Asia 2.625
SA - Sud America 430
AF - Africa 89
OC - Oceania 13
Totale 10.516
Nazione #
US - Stati Uniti d'America 3.312
RU - Federazione Russa 1.917
SG - Singapore 1.120
CN - Cina 696
GB - Regno Unito 537
IT - Italia 406
BR - Brasile 352
HK - Hong Kong 295
VN - Vietnam 208
DE - Germania 203
SE - Svezia 185
IE - Irlanda 181
FR - Francia 178
FI - Finlandia 135
KR - Corea 75
CA - Canada 74
ID - Indonesia 51
IN - India 45
UA - Ucraina 36
AR - Argentina 30
NL - Olanda 28
ES - Italia 27
PL - Polonia 25
AT - Austria 24
TG - Togo 23
ZA - Sudafrica 23
BD - Bangladesh 22
BJ - Benin 22
JP - Giappone 17
MX - Messico 16
BE - Belgio 14
IQ - Iraq 14
CO - Colombia 10
TR - Turchia 10
VE - Venezuela 10
IL - Israele 8
LT - Lituania 8
PK - Pakistan 8
EC - Ecuador 7
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
TW - Taiwan 7
UY - Uruguay 7
AU - Australia 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
MA - Marocco 6
GR - Grecia 5
PE - Perù 5
UZ - Uzbekistan 5
KE - Kenya 4
NP - Nepal 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
EG - Egitto 3
HU - Ungheria 3
JO - Giordania 3
MD - Moldavia 3
MY - Malesia 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
CM - Camerun 2
EE - Estonia 2
ET - Etiopia 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TJ - Tagikistan 1
Totale 10.515
Città #
Moscow 640
Singapore 466
Dallas 459
Chandler 411
Southend 397
Ashburn 318
Hong Kong 286
Dublin 165
Beijing 153
Verona 151
New York 126
Houston 125
Jacksonville 114
Los Angeles 105
The Dalles 77
Woodbridge 73
Lawrence 64
Princeton 64
Wilmington 64
Ann Arbor 62
Munich 59
Helsinki 57
Santa Clara 49
Buffalo 48
Ho Chi Minh City 46
London 44
Dong Ket 41
Jakarta 41
Redondo Beach 41
Seattle 39
Columbus 38
Boardman 34
Jinan 32
São Paulo 31
Chicago 29
Hanoi 28
Lappeenranta 28
Kent 27
Nanjing 27
Sindelfingen 26
Lomé 23
Shenyang 23
Cotonou 22
Toronto 22
Redwood City 21
Tianjin 21
Turku 21
Zhengzhou 21
Nuremberg 20
Warsaw 20
Dearborn 19
Montreal 19
Washington 19
Milan 17
Phoenix 17
Council Bluffs 16
Denver 16
Rome 16
Atlanta 15
San Francisco 15
Tokyo 15
Amsterdam 14
Brooklyn 14
Frankfurt am Main 14
Hebei 14
Johannesburg 14
Poplar 14
Redmond 14
Vienna 14
Boston 13
Brussels 13
Guangzhou 13
Haikou 13
Manchester 13
Nanchang 13
Düsseldorf 11
Jiaxing 11
Ningbo 11
Norwalk 11
Stockholm 11
Belo Horizonte 10
Chennai 10
Mexico City 10
Rio de Janeiro 10
Taizhou 10
Hangzhou 9
Padova 9
Roverbella 9
Buenos Aires 8
Falkenstein 8
Haiphong 8
Tampa 8
Da Nang 7
Miami 7
Orem 7
Saint Petersburg 7
Seoul 7
Vancouver 7
Changsha 6
Falls Church 6
Totale 5.891
Nome #
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 442
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 198
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 195
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 189
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 168
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 168
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 164
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 162
First-generation antipsychotics and QTc: any role for mediating variables? 156
Antipsychotic drug exposure and risk of myocardial infarction 156
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 156
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 154
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 153
Antidepressants for the treatment of depression in people with cancer 151
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 146
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials 145
Antipsychotic combinations in schizophrenia 144
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 143
Implementation of treatment guidelines for specialist mental health care 143
Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure 137
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 136
Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study 135
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies 134
Can we identify the active ingredients of behaviour change interventions for coronary heart disease patients? A systematic review and meta-analysis 133
Can a digital medicine system improve adherence to antipsychotic treatment? 130
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 130
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 130
Long-acting antipsychotics: patient’s features and prescribing attitudes in Italy. Findings from the cross-sectional phase of an observational, longitudinal, multicenter study. 127
Effectiveness of a stepped-care programme of WHO psychological interventions in migrant populations resettled in Italy: study protocol for the RESPOND randomized controlled trial 122
Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy 121
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 120
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 118
Umbrella systematic review and meta-analysis: physical activity as an effective therapeutic strategy for improving psychosocial outcomes in children and adolescents 115
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance 115
Prevalence and Correlates of Psychological Distress and Psychiatric Disorders in Asylum Seekers and Refugees Resettled in an Italian Catchment Area 114
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review 113
Cost-effectiveness of the Self-Help Plus Intervention for Adult Syrian Refugees Hosted in Turkey 113
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 112
Antidepressants for the treatment of depression in people with cancer 111
Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network meta-analysis 110
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study 110
Public health psychopharmacology: a new research discipline comes of age? 109
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 105
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 104
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders 103
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 103
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 103
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 102
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) 102
Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studies 101
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 100
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 99
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 98
Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial 97
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 95
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis 94
Efficacy of interventions to reduce coercive treatment in mental health services: umbrella review of randomised evidence 94
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 93
Effects of COVID-19 pandemic on psychiatric and psychological consultation-liaison contacts in a general hospital in North-East of Italy: a retrospective study 93
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study 92
SSRI plus supportive care more effective than supportive care alone for mild to moderate depression 89
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 88
Medicine-based evidence: the case of antidepressants in patients with coronary artery disease 87
Vortioxetine for depression in adults 86
Esketamine clinical trials: reply to Maju et al 85
Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis 85
Effectiveness of a stepped-care programme of WHO psychological interventions in a population of migrants: results from the RESPOND randomized controlled trial 84
Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis 82
Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis 81
Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health 80
Regulatory meta-analyses for the evaluation of psychotropic medicines 79
Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia 77
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 77
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 73
Association between adverse childhood experiences and suicidal behavior in affective disorders: A systematic review and meta-analysis 72
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study 72
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 72
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study 72
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis 71
Association between sleep disturbances and suicidal behavior in adolescents: a systematic review and meta-analysis 69
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 68
The role of attitudes toward medication and treatment adherence in the clinical response to LAIs: findings from the STAR Network Depot Study 68
Risk factors for mental disorder development in asylum seekers and refugees resettled in Western Europe and Turkey: Participant-level analysis of two large prevention studies 64
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 62
Are sleep disturbances a risk factor for suicidal behavior in the first episode of psychosis? Evidence from a systematic review 61
Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study 59
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 58
Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms 58
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 58
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level 57
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 56
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 56
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 56
Preventing relapse in schizophrenia needs better evidence 55
Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials 53
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 51
Expanding access to long-acting antipsychotics in low-income and middle-income countries 47
Factors associated with medication adherence to long-acting injectable antipsychotics: results from the STAR Network Depot Study 47
Esketamine for treatment-resistant depression in adults 44
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 43
Totale 10.608
Categoria #
all - tutte 39.801
article - articoli 39.470
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 331
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 51 15 7 16 27 42 81
2021/2022494 21 76 2 45 66 9 17 35 24 14 52 133
2022/20231.291 73 133 101 202 111 268 33 100 167 30 43 30
2023/2024909 58 69 65 87 109 143 42 67 19 47 117 86
2024/20252.308 108 97 119 377 136 117 93 115 345 227 192 382
2025/20264.235 453 255 532 1.090 1.715 190 0 0 0 0 0 0
Totale 10.690